Jordan | Programme areas | Good Governance for Medicines programme

Good Governance for Medicines programme

Print PDF

Overview

The Good Governance for Medicines programme raises awareness of the need for good governance in the pharmaceutical sector. Its ultimate aim is to ensure that essential medicines reach the people who need them by the application of transparent, accountable administrative procedures and by promoting ethical practices.

The programme is being implemented in three steps. The first phase is to measure transparency in the public pharmaceutical sector by providing a comprehensive analysis of the level of transparency and its vulnerability to corruption. The second phase is the development of a framework for good governance in the pharmaceutical sector, in partnership with other key stakeholders. The third phase will be to implement a national programme of good governance for medicines and institutionalization.

In 2010 Jordan developed the foundations of a framework for good governance for medicines, which laid out ethical principles and a code of conduct, developed anti-corruption legislation and promoted moral leadership.

Related links

WHO Good Governance for Medicines programme

Key health-related statistics

Total population in thousands 10 053
Total expenditure on health (% of general government expenditure) 13.7
Maternal mortality ratio (per 100 000 live births) 58
Primary health care units and centres (per 10 000 population) 6.9
Life expectancy 74.3

Source: Framework for health information systems and core indicators for monitoring health situation and health system performance, 2018

See Jordan country profile

Regional Health Observatory

Contact us

WHO Representative
PO Box 811547
Amman
11181

Jordan WHO headquarters page